Purinergic Ca 2+ Signaling as a Novel Mechanism of Drug Tolerance in BRAF-Mutant Melanoma.

Autor: Stauffer, Philip E.1 (AUTHOR), Brinkley, Jordon1 (AUTHOR), Jacobson, David A.2 (AUTHOR) david.a.jacobson@vanderbilt.edu, Quaranta, Vito1,3 (AUTHOR), Tyson, Darren R.1 (AUTHOR) darren.tyson@vanderbilt.edu
Zdroj: Cancers. Jul2024, Vol. 16 Issue 13, p2426. 23p.
Databáze: Academic Search Ultimate